Piroxicam in the treatment of acute gout: a multicentre open study in general practice.
Twenty-nine patients with acute gout were treated with piroxicam (40 mg daily for 5 days) in a multicentre general practitioner study. Pain relief was noticeable within 4 hours of the first dose and thereafter proceeded steadily, together with the early relief of other symptoms associated with acute gout. The prompt relief of symptoms was accompanied by a fall in serum uric acid. Piroxicam was well tolerated, eight experiencing side-effects that were mainly mild and gastro-intestinal in nature. The drug seems to be highly effective and safe in the treatment of acute gout.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
D006074:Gout Suppressants; D011725:Pyridines; D013843:Thiazines; D014527:Uric Acid